These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 26466806)

  • 1. Beyond classical derivatization: analyte 'derivatives' in the bioanalysis of endogenous and exogenous compounds.
    Barnaby OS; Benitex Y; Cantone JL; McNaney CA; Olah TV; Drexler DM
    Bioanalysis; 2015 Oct; 7(19):2501-13. PubMed ID: 26466806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioanalytical method development and validation: Critical concepts and strategies.
    Moein MM; El Beqqali A; Abdel-Rehim M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Feb; 1043():3-11. PubMed ID: 27720355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent development of chemical derivatization in LC-MS for biomedical approaches.
    Ohno K; Yamashita K
    Bioanalysis; 2015 Oct; 7(19):2489-99. PubMed ID: 26478519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive investigation of the influence of acidic, basic, and organic mobile phase compositions on bioanalytical assay sensitivity in positive ESI mode LC/MS/MS.
    Rainville PD; Smith NW; Cowan D; Plumb RS
    J Pharm Biomed Anal; 2012 Feb; 59():138-50. PubMed ID: 22088477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical derivatization as a tool for optimizing MS response in sensitive LC-MS/MS bioanalysis and its role in pharmacokinetic studies.
    Niwa M
    Bioanalysis; 2012 Jan; 4(2):213-20. PubMed ID: 22250803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies in quantitative LC-MS/MS analysis of unstable small molecules in biological matrices.
    Li W; Zhang J; Tse FL
    Biomed Chromatogr; 2011 Jan; 25(1-2):258-77. PubMed ID: 21204113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioanalytical derivatization: is there still room for development?
    Giera M
    Bioanalysis; 2015 Oct; 7(19):2439-41. PubMed ID: 26457481
    [No Abstract]   [Full Text] [Related]  

  • 8. Development of a micro-turbulent flow chromatography focus mode method for drug quantitation in discovery bioanalysis.
    Turnpenny P; Fraier D; Chassaing C; Duckworth J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep; 856(1-2):131-40. PubMed ID: 17574938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy: a potential quandary in regulated bioanalysis of 'endogenous' analytes.
    Jenkins RG
    Bioanalysis; 2016 Dec; 8(23):2393-2397. PubMed ID: 27855511
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemical derivatization in bioanalysis.
    Perez HL; Evans CA
    Bioanalysis; 2015 Oct; 7(19):2435-7. PubMed ID: 26526650
    [No Abstract]   [Full Text] [Related]  

  • 11. Systematic evaluation of supported liquid extraction in reducing matrix effect and improving extraction efficiency in LC-MS/MS based bioanalysis for 10 model pharmaceutical compounds.
    Jiang H; Cao H; Zhang Y; Fast DM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Apr; 891-892():71-80. PubMed ID: 22410088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of matrix effects in LC-MS/MS bioanalysis.
    Bergeron A; Garofolo F
    Bioanalysis; 2013 Oct; 5(19):2331-2. PubMed ID: 24066616
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of high-resolution mass spectrometry to investigate a metabolite interference during liquid chromatography/tandem mass spectrometric quantification of a small molecule in toxicokinetic study samples.
    Furlong M; Bessire A; Song W; Huntington C; Groeber E
    Rapid Commun Mass Spectrom; 2010 Jul; 24(13):1902-10. PubMed ID: 20533320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capillary electrophoresis-mass spectrometry, an attractive tool for drug bioanalysis and biomarker discovery.
    Servais AC; Crommen J; Fillet M
    Electrophoresis; 2006 Jul; 27(13):2616-29. PubMed ID: 16817163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ion suppression and enhancement effects of co-eluting analytes in multi-analyte approaches: systematic investigation using ultra-high-performance liquid chromatography/mass spectrometry with atmospheric-pressure chemical ionization or electrospray ionization.
    Remane D; Meyer MR; Wissenbach DK; Maurer HH
    Rapid Commun Mass Spectrom; 2010 Nov; 24(21):3103-8. PubMed ID: 20941756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential of HILIC-MS in quantitative bioanalysis of drugs and drug metabolites.
    Hsieh Y
    J Sep Sci; 2008 May; 31(9):1481-91. PubMed ID: 18428187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The development and assessment of high-throughput mass spectrometry-based methods for the quantification of a nanoparticle drug delivery agent in cellular lysate.
    Buse J; Purves RW; Verrall RE; Badea I; Zhang H; Mulligan CC; Peru KM; Bailey J; Headley JV; El-Aneed A
    J Mass Spectrom; 2014 Nov; 49(11):1171-80. PubMed ID: 25395133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of biotherapeutic targets: new opportunities with immunoaffinity LC-MS/MS.
    Neubert H; Palandra J; Fernández Ocaña M
    Bioanalysis; 2014; 6(13):1731-3. PubMed ID: 25157479
    [No Abstract]   [Full Text] [Related]  

  • 19. Addressing the need for biomarker liquid chromatography/mass spectrometry assays: a protocol for effective method development for the bioanalysis of endogenous compounds in cerebrospinal fluid.
    Benitex Y; McNaney CA; Luchetti D; Schaeffer E; Olah TV; Morgan DG; Drexler DM
    Rapid Commun Mass Spectrom; 2013 Aug; 27(16):1882-6. PubMed ID: 23857934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical derivatization in LC-MS bioanalysis: current & future challenges.
    Niwa M; Watanabe M; Watanabe N
    Bioanalysis; 2015 Oct; 7(19):2443-9. PubMed ID: 26466805
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.